In the novel CHECKPOINT, Lance Simard, a brilliant scientist tormented by the loss of his mother to cancer, stumbles upon a groundbreaking discovery. Having developed a drug named CP1, Lance faces initial disappointment when it fails its intended purpose. However, his life takes an unexpected turn when he encounters a mysterious doctor, who unveils CP1's hidden potential as a cancer cure. Simultaneously, FDA Special Agent Justine Burke investigates this doctor for using his own unconventional cancer treatment methods, leading her to uncover Project Platinum – a secret government organization conspiring with Big Pharma to suppress new cancer treatments. As Lance grapples with the unintended consequences of his research, a web of intrigue unfolds, involving stolen trade secrets, international conspiracies, and personal vendettas. CHECKPOINT ultimately reveals the potential for a transformative cure in the most unexpected places.
Maya Angelou
May 28 - June 1, 2024
New York City
Nashville, TN
London, UK
New York City
GK Daffu is a PhD-trained molecular biologist, with numerous scientific publications in peer-reviewed journals. She spent many years in academia as a Research Scientist before becoming a Medical Writer. She currently works as a Medical Strategist for a pharmaceutical advertising agency out of New York City where she specializes in oncology. She has completed courses in screenwriting (Rekindle School) and creative writing (Curtis Brown Creative). She has also completed ITW's 2024 Online Thriller School. She spends her time between Seattle, New York City, and Spain. CHECKPOINT is her first novel. She is currently working on the second novel in the series called ANTIDOTE.
Copyright © 2024 GK DAFFU - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.